1
|
Vala DP, Dunne Miller A, Atmasidha A, Parmar MP, Patel CD, Upadhyay DB, Bhalodiya SS, González-Bakker A, Khan AN, Nogales J, Padrón JM, Banerjee S, Patel HM. Click-chemistry mediated synthesis of OTBN-1,2,3-Triazole derivatives exhibiting STK33 inhibition with diverse anti-cancer activities. Bioorg Chem 2024; 149:107485. [PMID: 38824700 DOI: 10.1016/j.bioorg.2024.107485] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2024] [Accepted: 05/20/2024] [Indexed: 06/04/2024]
Abstract
There is a continuous and pressing need to establish new brain-penetrant bioactive compounds with anti-cancer properties. To this end, a new series of 4'-((4-substituted-4,5-dihydro-1H-1,2,3-triazol-1-yl)methyl)-[1,1'-biphenyl]-2-carbonitrile (OTBN-1,2,3-triazole) derivatives were synthesized by click chemistry. The series of bioactive compounds were designed and synthesized from diverse alkynes and N3-OTBN, using copper (II) acetate monohydrate in aqueous dimethylformamide at room temperature. Besides being highly cost-effective and significantly reducing synthesis, the reaction yielded 91-98 % of the target products without the need of any additional steps or chromatographic techniques. Two analogues exhibit promising anti-cancer biological activities. Analogue 4l shows highly specific cytostatic activity against lung cancer cells, while analogue 4k exhibits pan-cancer anti-growth activity. A kinase screen suggests compound 4k has single-digit micromolar activity against kinase STK33. High STK33 RNA expression correlates strongly with poorer patient outcomes in both adult and pediatric glioma. Compound 4k potently inhibits cell proliferation, invasion, and 3D neurosphere formation in primary patient-derived glioma cell lines. The observed anti-cancer activity is enhanced in combination with specific clinically relevant small molecule inhibitors. Herein we establish a novel biochemical kinase inhibitory function for click-chemistry-derived OTBN-1,2,3-triazole analogues and further report their anti-cancer activity in vitro for the first time.
Collapse
Affiliation(s)
- Disha P Vala
- Department of Chemistry, Sardar Patel University, Vallabh Vidyanagar-388 120, Gujarat, India.
| | - Amy Dunne Miller
- Department of Cellular and Systems Medicine, School of Medicine, University of Dundee, Dundee DD1 9SY, UK.
| | - Aditi Atmasidha
- Department of Cellular and Systems Medicine, School of Medicine, University of Dundee, Dundee DD1 9SY, UK.
| | - Mehul P Parmar
- Department of Chemistry, Sardar Patel University, Vallabh Vidyanagar-388 120, Gujarat, India
| | - Chirag D Patel
- Department of Chemistry, Sardar Patel University, Vallabh Vidyanagar-388 120, Gujarat, India
| | - Dipti B Upadhyay
- Department of Chemistry, Sardar Patel University, Vallabh Vidyanagar-388 120, Gujarat, India
| | - Savan S Bhalodiya
- Department of Chemistry, Sardar Patel University, Vallabh Vidyanagar-388 120, Gujarat, India
| | - Aday González-Bakker
- BioLab, Instituto Universitario de Bio-Orgánica Antonio González, Universidad de La Laguna, Avda. Astrofísico Francisco Sánchez 2, 38206 La Laguna, Spain.
| | - Adam N Khan
- BioLab, Instituto Universitario de Bio-Orgánica Antonio González, Universidad de La Laguna, Avda. Astrofísico Francisco Sánchez 2, 38206 La Laguna, Spain.
| | - Joaquina Nogales
- Department of Cellular and Systems Medicine, School of Medicine, University of Dundee, Dundee DD1 9SY, UK.
| | - José M Padrón
- BioLab, Instituto Universitario de Bio-Orgánica Antonio González, Universidad de La Laguna, Avda. Astrofísico Francisco Sánchez 2, 38206 La Laguna, Spain.
| | - Sourav Banerjee
- Department of Cellular and Systems Medicine, School of Medicine, University of Dundee, Dundee DD1 9SY, UK.
| | - Hitendra M Patel
- Department of Chemistry, Sardar Patel University, Vallabh Vidyanagar-388 120, Gujarat, India.
| |
Collapse
|
2
|
Lv H, Miao M, Wu Z, Huang C, Tang X, Yan R. Hyaluronic acid-coated liposomes for enhanced in vivo efficacy of neogambogic acid via active tumor cell targeting and prolonged systemic exposure. J Liposome Res 2024:1-12. [PMID: 38733152 DOI: 10.1080/08982104.2024.2348643] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2023] [Accepted: 04/23/2024] [Indexed: 05/13/2024]
Abstract
Neogambogic acid (NGA), which possesses a variety of anticancer activities, is visualized as an anticancer bioactive ingredient. However, the huge vascular stimulation, poor aqueous solubility, and short half-life restricted its clinical use. In this work, an effective nanocarrier was explored to reduce toxicity and enhance the tumor-targeted delivery. Two liposomal formulations, neogambogic acid liposomes (NGA-L), and hyaluronic acid-coated neogambogic acid liposomes (HA-NGA-L) were prepared and characterized with high encapsulation efficiency, slow pattern of drug release, narrow size distribution and higher stability. The cytotoxicity and cellular uptake of HA-NGA-L were higher than those of NGA-L in MDA-MB-231 cells (high CD44 expression), while no obvious differences in MCF-7 cells with (low CD44 expression), suggesting the CD44-mediated cellular internalization of hyaluronic acid-modified liposomes enhanced the cytotoxicity. Mechanistically, elevation of Bax and caspase-3 as well as downregulation of Bcl-2 led to cell apoptosis. Besides, the vascular stimulation and the hemolysis test indicated good safety of HA-NGA-L. In addition, HA-NGA-L was the effective nanocarrier to repress tumor proliferation in MDA-MB-231 tumor xenograft mouse through CD44 mediated active targeting without any obvious histopathological abnormities on major organs. Immunohistochemistry analysis revealed the enhanced elevation of Bax and caspase-3, and reduced expression of Bcl-2 contribute to apoptosis in tumors. Meanwhile, HA-NGA-L increased the AUC and t1/2 by 5.34-fold and 3.94-fold, respectively. In summary, the present study shows that HA-NGA-L may be safe and effective for the tumor-targeted delivery of neogambogic acid.
Collapse
Affiliation(s)
- Hongzhen Lv
- School of Basic Medical Sciences, Jiangsu Vocational College of Medicine, Yancheng, China
| | - Miao Miao
- Disease Prevention and Control Center of Tongshan District, Xuzhou, China
- Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China
| | - Zhichao Wu
- Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China
| | - Cheng Huang
- School of Traditional Chinese Medicine, Jiangsu Vocational College of Medicine, Yancheng, China
| | - Xiaozhu Tang
- School of Medicine and Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, China
| | - Rugen Yan
- School of Integrated Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China
| |
Collapse
|
3
|
Viana P, Hamar P. Targeting the heat shock response induced by modulated electro-hyperthermia (mEHT) in cancer. Biochim Biophys Acta Rev Cancer 2024; 1879:189069. [PMID: 38176599 DOI: 10.1016/j.bbcan.2023.189069] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/20/2023] [Revised: 12/20/2023] [Accepted: 12/28/2023] [Indexed: 01/06/2024]
Abstract
The Heat Shock Response (HSR) is a cellular stress reaction crucial for cell survival against stressors, including heat, in both healthy and cancer cells. Modulated electro-hyperthermia (mEHT) is an emerging non-invasive cancer therapy utilizing electromagnetic fields to selectively target cancer cells via temperature-dependent and independent mechanisms. However, mEHT triggers HSR in treated cells. Despite demonstrated efficacy in cancer treatment, understanding the underlying molecular mechanisms for improved therapeutic outcomes remains a focus. This review examines the HSR induced by mEHT in cancer cells, discussing potential strategies to modulate it for enhanced tumor-killing effects. Approaches such as HSF1 gene-knockdown and small molecule inhibitors like KRIBB11 are explored to downregulate the HSR and augment tumor destruction. We emphasize the impact of HSR inhibition on cancer cell viability, mEHT sensitivity, and potential synergistic effects, addressing challenges and future directions. This understanding offers opportunities for optimizing treatment strategies and advancing precision medicine in cancer therapy.
Collapse
Affiliation(s)
- Pedro Viana
- Institute of Translational Medicine, Semmelweis University, Tűzoltó utca 37-49, 1094 Budapest, Hungary.
| | - Péter Hamar
- Institute of Translational Medicine, Semmelweis University, Tűzoltó utca 37-49, 1094 Budapest, Hungary.
| |
Collapse
|
4
|
Keenlyside A, Marples T, Gao Z, Hu H, Nicely LG, Nogales J, Li H, Landgraf L, Solth A, Melzer A, Hossain-Ibrahim K, Huang Z, Banerjee S, Joseph J. Development and optimisation of in vitro sonodynamic therapy for glioblastoma. Sci Rep 2023; 13:20215. [PMID: 37980454 PMCID: PMC10657375 DOI: 10.1038/s41598-023-47562-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/2023] [Accepted: 11/15/2023] [Indexed: 11/20/2023] Open
Abstract
Sonodynamic therapy (SDT) is currently on critical path for glioblastoma therapeutics. SDT is a non-invasive approach utilising focused ultrasound to activate photosensitisers like 5-ALA to impede tumour growth. Unfortunately, the molecular mechanisms underlying the therapeutic functions of SDT remain enigmatic. This is primarily due to the lack of intricately optimised instrumentation capable of modulating SDT delivery to glioma cells in vitro. Consequently, very little information is available on the effects of SDT on glioma stem cells which are key drivers of gliomagenesis and recurrence. To address this, the current study has developed and validated an automated in vitro SDT system to allow the application and mapping of focused ultrasound fields under varied exposure conditions and setup configurations. The study optimizes ultrasound frequency, intensity, plate base material, thermal effect, and the integration of live cells. Indeed, in the presence of 5-ALA, focused ultrasound induces apoptotic cell death in primary patient-derived glioma cells with concurrent upregulation of intracellular reactive oxygen species. Intriguingly, primary glioma stem neurospheres also exhibit remarkably reduced 3D growth upon SDT exposure. Taken together, the study reports an in vitro system for SDT applications on tissue culture-based disease models to potentially benchmark the novel approach to the current standard-of-care.
Collapse
Affiliation(s)
- Andrew Keenlyside
- Centre for Medical Engineering and Technology (CMET), University of Dundee, Nethergate, Dundee, DD1 4HN, UK
- Department of Cellular and Systems Medicine, School of Medicine, University of Dundee, Dundee, DD1 9SY, UK
| | - Theodore Marples
- Centre for Medical Engineering and Technology (CMET), University of Dundee, Nethergate, Dundee, DD1 4HN, UK
| | - Zifan Gao
- Centre for Medical Engineering and Technology (CMET), University of Dundee, Nethergate, Dundee, DD1 4HN, UK
- Department of Biomedical Engineering, School of Science and Engineering, University of Dundee, Dundee, DD1 4HN, UK
| | - Hong Hu
- Centre for Medical Engineering and Technology (CMET), University of Dundee, Nethergate, Dundee, DD1 4HN, UK
- Department of Biomedical Engineering, School of Science and Engineering, University of Dundee, Dundee, DD1 4HN, UK
| | - Lynden Guy Nicely
- Department of Cellular and Systems Medicine, School of Medicine, University of Dundee, Dundee, DD1 9SY, UK
| | - Joaquina Nogales
- Department of Cellular and Systems Medicine, School of Medicine, University of Dundee, Dundee, DD1 9SY, UK
| | - Han Li
- Centre for Medical Engineering and Technology (CMET), University of Dundee, Nethergate, Dundee, DD1 4HN, UK
- Department of Biomedical Engineering, School of Science and Engineering, University of Dundee, Dundee, DD1 4HN, UK
| | - Lisa Landgraf
- Innovation Center Computer Assisted Surgery, Institute at the Faculty of Medicine, Leipzig University, 04103, Leipzig, Germany
| | - Anna Solth
- Department of Neurosurgery, Ninewells Hospital and Medical School, NHS Tayside, Dundee, DD1 9SY, UK
| | - Andreas Melzer
- Centre for Medical Engineering and Technology (CMET), University of Dundee, Nethergate, Dundee, DD1 4HN, UK
- Department of Biomedical Engineering, School of Science and Engineering, University of Dundee, Dundee, DD1 4HN, UK
- Innovation Center Computer Assisted Surgery, Institute at the Faculty of Medicine, Leipzig University, 04103, Leipzig, Germany
| | - Kismet Hossain-Ibrahim
- Department of Neurosurgery, Ninewells Hospital and Medical School, NHS Tayside, Dundee, DD1 9SY, UK
| | - Zhihong Huang
- Centre for Medical Engineering and Technology (CMET), University of Dundee, Nethergate, Dundee, DD1 4HN, UK
- Department of Biomedical Engineering, School of Science and Engineering, University of Dundee, Dundee, DD1 4HN, UK
| | - Sourav Banerjee
- Department of Cellular and Systems Medicine, School of Medicine, University of Dundee, Dundee, DD1 9SY, UK.
| | - James Joseph
- Centre for Medical Engineering and Technology (CMET), University of Dundee, Nethergate, Dundee, DD1 4HN, UK.
- Department of Biomedical Engineering, School of Science and Engineering, University of Dundee, Dundee, DD1 4HN, UK.
| |
Collapse
|
5
|
Mochimaru Y, Yoshida K. Functional Roles of DYRK2 as a Tumor Regulator. Curr Issues Mol Biol 2023; 45:8539-8551. [PMID: 37886981 PMCID: PMC10605165 DOI: 10.3390/cimb45100538] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2023] [Revised: 10/23/2023] [Accepted: 10/23/2023] [Indexed: 10/28/2023] Open
Abstract
The dual-specificity tyrosine phosphorylation-regulated kinase 2 (DYRK2) regulates the induction of apoptosis and DNA repair, metastasis inhibition, cell cycle G1/S transition, protein scaffold stability for E3 ligase complexes, and embryogenesis. Owing to these functions, DYRK2 is thought to regulate tumorigenesis, and its function in cancer has been investigated. Notably, DYRK2 has been reported to function as a tumor suppressor; however, it has also been reported to act as an oncogene in some cancers. This discrepancy makes it difficult to elucidate the conserved functions of DYRK2 in cancer. Here, we reviewed the functions of DYRK2 in various cancers. Patient tissue samples were evaluated for each cancer type. Although some studies have used cell lines and/or xenografts to elucidate the mechanism of DYRK2 function, these studies are not sufficient to understand the role of DYRK2 in cancers. In particular, studies using genetically modified mice would help us to understand the reported functional duality of DYRK2 in cancer.
Collapse
Affiliation(s)
| | - Kiyotsugu Yoshida
- Department of Biochemistry, The Jikei University School of Medicine, Tokyo 105-8461, Japan;
| |
Collapse
|